Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Other Non-Current Assets (2016 - 2025)

ImmunityBio (IBRX) has disclosed Other Non-Current Assets for 12 consecutive years, with $4.5 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets rose 547.14% to $4.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.5 million through Dec 2025, up 547.14% year-over-year, with the annual reading at $4.5 million for FY2025, 547.14% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $4.5 million at ImmunityBio, up from $4.5 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $7.4 million in Q3 2021, with the low at $374000.0 in Q2 2021.
  • Average Other Non-Current Assets over 5 years is $3.7 million, with a median of $3.7 million recorded in 2023.
  • The sharpest move saw Other Non-Current Assets soared 6485.84% in 2021, then plummeted 86.15% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $6.8 million in 2021, then fell by 28.27% to $4.9 million in 2022, then plummeted by 40.74% to $2.9 million in 2023, then crashed by 75.69% to $700000.0 in 2024, then skyrocketed by 547.14% to $4.5 million in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $4.5 million, $4.5 million, and $433000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.